ABHD7 activators belong to a class of chemical compounds that modulate the activity of the enzyme ABHD7, which stands for Alpha/Beta-Hydrolase Domain-containing protein 7. ABHD7 is one of the many enzymes in the alpha/beta-hydrolase fold family, characterized by their structural motif that includes an alpha/beta-sheet core with a catalytic triad typically consisting of serine, aspartate, and histidine residues. These enzymes are involved in a wide array of biological processes due to their diverse substrate specificities and reaction types. ABHD7 activators, therefore, are molecules that interact with this enzyme, resulting in an increase in its enzymatic activity. The specificity of these activators to ABHD7 is vital, as it ensures that the modulation of the enzyme's activity is as targeted as possible, to avoid off-target effects that could alter the activity of other enzymes within the alpha/beta-hydrolase fold family.
The design and identification of ABHD7 activators require a deep understanding of the enzyme's structure and the dynamics of its active site. These activators may bind to the enzyme in a way that promotes the optimal positioning of its substrates or may induce conformational changes that enhance the enzyme's catalytic efficiency. The interaction between ABHD7 activators and the enzyme can be reversible or irreversible, depending on the nature of the chemical bond formed during the activation process. Reversible activators are often preferred, as they allow for a more controlled modulation of the enzyme's activity. The molecular architecture of these activators is generally tailored to fit into the active site of ABHD7 or to interact with specific allosteric sites that can modulate the enzyme's function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Adenylyl cyclase activator that increases cAMP levels, which can influence the regulation and activity of hydrolases like ABHD7. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
PDE inhibitor leading to elevated cAMP levels, potentially affecting the function of hydrolases such as ABHD7. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
Membrane-permeable cAMP analog that can modulate cellular processes linked with hydrolase activity including ABHD7. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
PDE3 inhibitor that elevates intracellular cAMP levels, possibly influencing the function of hydrolases like ABHD7. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
PDE4 inhibitor that can affect cAMP levels in cells, indirectly affecting hydrolase activity, potentially including ABHD7. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PKC activator, which might influence cellular processes or pathways linked to hydrolase function including ABHD7. | ||||||
H-89 dihydrochloride | 130964-39-5 | sc-3537 sc-3537A | 1 mg 10 mg | $94.00 $186.00 | 71 | |
PKA inhibitor that modulates cAMP-related pathways, possibly impacting the activity of hydrolases such as ABHD7 indirectly. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
Intracellular calcium chelator that can modulate calcium-dependent cellular processes potentially influencing ABHD7. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium ionophore that alters intracellular calcium levels, potentially affecting proteins like ABHD7. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Broad-spectrum kinase inhibitor that can affect numerous pathways, potentially indirectly influencing hydrolase function including ABHD7. | ||||||